ArticleClinical and translational science2021

Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off-label in the first wave of COVID-19.

Annie Delaunois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.